期刊文献+

急性白血病病人血清TNF-α和sIL-2R的测定 被引量:2

THE VALUE OF TUMOR NECROSIS FACTOR-α AND SOLUBLE INTERLEUKIN-2 RECEPTOR IN PATIENTS WITH ACUTE LEUKEMIA
暂未订购
导出
摘要 ①目的 探讨肿瘤坏死因子α(TNF α)和可溶性白细胞介素 2受体 (sIL 2R)与急性白血病的关系。②方法 用双抗夹心ELISA方法 ,检测 78例急性白血病病人发病期和缓解期血清TNF α和sIL 2R水平 ,并与 43例健康献血员进行比较。③结果 ANLL和ALL病人血清TNF α和sIL 2R水平均较正常对照组显著升高 (F =4.93,5 .2 5 ,q =3 .0 2~ 4.34,P <0 .0 1) ,急性白血病病人缓解前和缓解后的TNF α和sIL 2R测定结果有明显差异(F =3 .98,4.5 2 ,q =5 .16~ 6 .0 7,P <0 .0 1)。 ④结论 监测急性白血病病人血清TNF α和sIL Objective To explore the relation between TNF-α,sIL-2R and acute leukemia. \ Methods The TNF-α and sIL-2R were assayed with ELISA in 78 cases of acute leukemia. \ Results The serum levels of TNF-α and sIL-2R in patients with acute leukemia were higher than those of normal controls(F= 4.93, 5.25 , q=3.02-4.34,P<0.01), and there was a significant difference between before and after remission(CR) (F=3.98,4.52,q=5.16-6.07,P<0.01). \ Conclusion The determination of serum TNF-α and sIL-2R levels was valuable in the diagnosis and evaluation of therapeutic effect for acute leukemia.
出处 《齐鲁医学杂志》 2001年第2期85-86,共2页 Medical Journal of Qilu
关键词 肿瘤坏死因子 白细胞介素受体 急性白血病 TNFΑ SIL-2R tumor necrosis factor receptors, interleukin-2 leukemia
  • 相关文献

参考文献2

二级参考文献5

  • 1团体著者,淋巴瘤学刊,1985年,8期,2页
  • 2张之南,血液病诊断及疗效标准,1991年
  • 3黄蓉蓉,标记免疫分析与临床,1995年,2期,33页
  • 4周廷冲,多肽生长因子.基础与临床,1992年,333页
  • 5汪月增,中华血液学杂志,1988年,9期,391页

共引文献18

同被引文献33

  • 1黄洪晖,陈芳源,钟济华,韩洁英,钟华,欧阳仁荣.急性白血病病人sIL-2R、IL-6水平和细胞免疫功能的研究[J].诊断学理论与实践,2002,1(1):45-46. 被引量:1
  • 2秦卫松,沈倍奋.肿瘤坏死因子α拮抗剂的研究进展[J].国外医学(免疫学分册),2005,28(1):24-27. 被引量:6
  • 3李大启.肿瘤坏死因子α与白血病的研究进展[J].国外医学(输血及血液学分册),1995,18(1):23-25. 被引量:5
  • 4Yu M, Zhou X, Niu L, et al. Targeting transmembrane TNF-asuppresses breast Cancer growth[J]. Cancer Res,2013,73(13):4061-4074.
  • 5Tsimberidou AM, Giles FJ. TNF-alpha targeted therapeutic ap-proaches in patients with hematologic malignancies [ J ]. ExpertRev Anticancer Ther,2002 ,2(3) : 277-286.
  • 6Singer MK, Assem M,Abdel Ghaffar AB, et al. Role of TNF-al-pha as a survival prognostic marker in chronic lymphocytic leuke-mia patients[J]. Egypt J Immunol,2011,18(1) :51-60.
  • 7Moon DO? Kim MO, Lee JD, et al. Rosmarinic acid sensitizes celldeath through suppression of TNF-alpha-induced NF-kappaB acti-vation and ROS Generation in human leukemia U937 cells[J].Cancer Lett,2010,288(2) : 183-191.
  • 8Ferrajoli A, Keating MJ , Manshouri T, et al. The clinical signifi-cance of tumor necrosis factor-alpha plasma level in patients hav-ing chronic lymphocytic leukemia[J]. Blood, 2002,100 (4):1215-1219.
  • 9Jourdan M,Tarte K,Legouffe E,et al. Tumor necrosis factor is asurvival and proliferation factor for human myeloma cells[J]. EurCytokine Netw, 1999,10(1) :65-70.
  • 10Tsubaki M,Komai M,Itoh T,et al. Inhibition of the tumour nec-rosis factor-alpha autocrine loop enhances the sensitivity of multi-ple myeloma cells to anticancer drugs[J]. Eur J Cancer, 2013,49?17):3708-3717.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部